Search - tctmd.com

Displaying 1 - 20 of 5394

Sort: Relevancy | Date

Hints of a Mortality Benefit With TTVR at 2 Years TRISCEND II

News Conference News ACC 2026

Hints of a Mortality Benefit With TTVR at 2 Years TRISCEND II

Yael L. Maxwell

April 07, 2026

Disparities Widen Across Regions as Global Hypertension Burden Grows

News Daily News

Disparities Widen Across Regions as Global Hypertension Burden Grows

April 03, 2026

Two Neutral IVUS Trials in Complex PCI—and One Positive—Spark Debate

News Conference News ACC 2026

Two Neutral IVUS Trials in Complex PCI—and One Positive—Spark Debate

April 02, 2026

TCTMD’s Top 10 Most Popular Stories for March 2026

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2026

April 01, 2026

Novel Cerebral Protection Device Matches Up Well With Sentinel in TAVI

News Conference News ACC 2026

Novel Cerebral Protection Device Matches Up Well With Sentinel in TAVI

March 30, 2026

SMART-DECISION: Stopping Beta-blockers Post-MI Safe in Stable Patients

News Conference News ACC 2026

SMART-DECISION: Stopping Beta-blockers Post-MI Safe in Stable Patients

Michael O'Riordan

March 30, 2026

Deferring PCI Until After TAVI Safe, Reduces Bleeding: PRO-TAVI

News Conference News ACC 2026

Deferring PCI Until After TAVI Safe, Reduces Bleeding: PRO-TAVI

Yael L. Maxwell

March 30, 2026

Transcatheter ViV a Solid Option for Failed Mitral Bioprostheses: SURViV

News Conference News ACC 2026

Transcatheter ViV a Solid Option for Failed Mitral Bioprostheses: SURViV

March 30, 2026

Impella Support in High-Risk PCI Doesn’t Help, Might Harm: CHIP-BCIS3

News Conference News ACC 2026

Impella Support in High-Risk PCI Doesn’t Help, Might Harm: CHIP-BCIS3

Yael L. Maxwell

March 29, 2026

PCSK9 Inhibitor Very Effective in High-risk Patients Without ASCVD: VESALIUS-CV

News Conference News ACC 2026

PCSK9 Inhibitor Very Effective in High-risk Patients Without ASCVD: VESALIUS-CV

Michael O'Riordan

March 29, 2026

Protect The Head To Head Trial: A Randomized Comparison Of Emboliner Embolic Protection System vs. Sentinel Cerebral Protection System During Transcatheter Aortic Valve Replacement

Presentation ACC 2026

Protect The Head To Head Trial: A Randomized Comparison Of Emboliner Embolic Protection System vs. Sentinel Cerebral Protection System During Transcatheter Aortic Valve Replacement

Presenter: Adam Greenbaum

March 29, 2026

Controlled trial of High-risk coronary Intervention with Percutaneous left ventricular unloading (CHIP-BCIS3)

Presentation ACC 2026

Controlled trial of High-risk coronary Intervention with Percutaneous left ventricular unloading (CHIP-BCIS3)

Presenter: Divaka Perera

March 29, 2026

Deferral of PCI in Patients Undergoing TAVI (PRO-TAVI): an Investigator-Initiated, Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial

Presentation ACC 2026

Deferral of PCI in Patients Undergoing TAVI (PRO-TAVI): an Investigator-Initiated, Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial

Presenter: Michiel Voskuil

March 29, 2026

Redo-SURgery vs Transcatheter Valve-In-Valve for Mitral Bioprosthetic Dysfunction: The SURVIV Trial

Presentation ACC 2026

Redo-SURgery vs Transcatheter Valve-In-Valve for Mitral Bioprosthetic Dysfunction: The SURVIV Trial

Presenter: Dimytri Siqueira

March 29, 2026

Transcatheter Edge-to-Edge Repair for Severe Isolated Tricuspid Regurgitation

Presentation ACC 2026

Transcatheter Edge-to-Edge Repair for Severe Isolated Tricuspid Regurgitation

Presenter: Erwan Donal

March 29, 2026

Very Low LDL Levels Best in Secondary Prevention: Ez-PAVE

News Conference News ACC 2026

Very Low LDL Levels Best in Secondary Prevention: Ez-PAVE

Yael L. Maxwell

March 28, 2026

HI-PEITHO: Catheter-Directed Therapy Bests Anticoagulation in Intermediate-Risk PE

News Conference News ACC 2026

HI-PEITHO: Catheter-Directed Therapy Bests Anticoagulation in Intermediate-Risk PE

March 28, 2026

CHAMPION-AF: A Win for Watchman FLX, but With Caveats

News Conference News ACC 2026

CHAMPION-AF: A Win for Watchman FLX, but With Caveats

March 28, 2026

Presentation ACC 2026

Intensive LDL cholesterol targeting in atherosclerotic cardiovascular disease: The Ez-PAVE randomized clinical trial

Presenter: Byeong-Keuk Kim

March 28, 2026

Several Factors Linked to Subsequent Events After TIA, Minor Stroke

News Daily News

Several Factors Linked to Subsequent Events After TIA, Minor Stroke

March 23, 2026

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.